Lello S - Search Results

1

Multifrequency bioelectrical impedance analysis in women with a normal and hypertensive pregnancy.

Valensise H, Andreoli A, Lello S, Magnani F, Romanini C, De Lorenzo A. Valensise H, et al. Among authors: lello s. Am J Clin Nutr. 2000 Sep;72(3):780-3. doi: 10.1093/ajcn/72.3.780. Am J Clin Nutr. 2000. PMID: 10966899

2

Body composition and androgen pattern in the early period of postmenopause.

De Lorenzo A, Lello S, Andreoli A, Guardianelli F, Romanini C. De Lorenzo A, et al. Among authors: lello s. Gynecol Endocrinol. 1998 Jun;12(3):171-7. doi: 10.3109/09513599809015541. Gynecol Endocrinol. 1998. PMID: 9675563 Free article.

3

Monitoring of hormone replacement therapy in postmenopausal women by transvaginal sonography and color flow doppler: study in different phases of sequential therapy.

Exacoustòs C, Lello S, Caporale E, Minghetti MC, Angelozzi D, Arduini D, Romanini C. Exacoustòs C, et al. Among authors: lello s. Fertil Steril. 1999 Mar;71(3):536-43. doi: 10.1016/s0015-0282(98)00481-6. Fertil Steril. 1999. PMID: 10065794 Free article.

4

Plasma 5alpha-androstane-3alpha,17betadiol, an endogenous steroid that positively modulates GABA(A) receptor function, and anxiety: a study in menopausal women.

Barbaccia ML, Lello S, Sidiropoulou T, Cocco T, Sorge RP, Cocchiarale A, Piermarini V, Sabato AF, Trabucchi M, Romanini C. Barbaccia ML, et al. Among authors: lello s. Psychoneuroendocrinology. 2000 Oct;25(7):659-75. doi: 10.1016/s0306-4530(00)00017-2. Psychoneuroendocrinology. 2000. PMID: 10938447

5

Clinical trial of a monophasic estroprogestin oral formulation containing 20 micrograms ethinyl estradiol and 75 micrograms gestodene.

Lello S, Monterubbianesi M, Guardianelli F, Bianchi C, Simonelli C. Lello S, et al. Gynecol Endocrinol. 2001 Aug;15(4):265-71. Gynecol Endocrinol. 2001. PMID: 11560099 Clinical Trial.

6

[Duloxetine in the treatment of urinary incontinence in women].

Lello S, Paoletti AM, Guardianelli F, Floris S, Melis M, Melis GB. Lello S, et al. Minerva Ginecol. 2004 Aug;56(4):349-52. Minerva Ginecol. 2004. PMID: 15377983 Review. Italian.

7

[Effect on skin and hormonal hyperandrogenic manifestations of an oral estroprogestin association containing ethynilestradiol 30 mg and drospirenone 3 mg].

Lello S, Primavera G, Colonna L, Vittori G, Guardianelli F, Pallotta P, Sorge R, Bilchugova E, Raskovic D. Lello S, et al. Minerva Ginecol. 2008 Jun;60(3):239-43. Minerva Ginecol. 2008. PMID: 18547986 Italian.

8

[Short-term effect of an estroprogestin containing ethinylestradiol 20 mcg + drospirenone 3 mg in 24+4 regimen at hormonal and cutaneous level in ovarian hyperandrogenism].

Lello S, Pacifico V, Primavera G, Guardianelli F, Sorge R, Paoletti AM, Melis GB, Raskovic D, Colonna L. Lello S, et al. Minerva Ginecol. 2010 Dec;62(6):509-13. Minerva Ginecol. 2010. PMID: 21079572 Italian.

9

Osteoporosis and cardiovascular disease: an update.

Lello S, Capozzi A, Scambia G. Lello S, et al. Gynecol Endocrinol. 2015;31(8):590-4. doi: 10.3109/09513590.2015.1041908. Epub 2015 Jun 3. Gynecol Endocrinol. 2015. PMID: 26036806 Free article. Review.

10

Hormone replacement therapy and prevention of chronic conditions.

Gambacciani M, Cagnacci A, Lello S. Gambacciani M, et al. Among authors: lello s. Climacteric. 2019 Jun;22(3):303-306. doi: 10.1080/13697137.2018.1551347. Epub 2019 Jan 10. Climacteric. 2019. PMID: 30626218 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters